Search Results 321-330 of 16272 for monoclonal antibody

  1. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

  2. Clinical trials - Oncology (Medical)

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as obinutuzumab, may ...

  3. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

    Monoclonal antibodies, such as atezolizumab, may block specific proteins found on white blood cells which may strengthen the immune system and control tumor ...

  4. Neurology - Clinical trials

    Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...

  5. Funding - Mayo Clinic Research

    Research organizations. The ABBVIE M15-566/M15-570 Study — Study to determine if using a monoclonal antibody tau antibody delays progression of mild Alzheimer's ...

  6. Mayo Clinic Q & A - Dr. Gregory Poland - COVID-19 Update - ...

    In other words, people getting an injection of monoclonal antibodies and being protected for the next 90 plus days. Dr. Halena Gazelka 19:52. How interesting.

  7. Anal Cancer Clinical Trials

    Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Nivolumab With or Without Ipilimumab in Treating ...

  8. Tackling the latest COVID-19 topics - Mayo Clinic News Network

    Antibody tests after having a COVID-19 vaccine. Monoclonal antibodies. COVID-19 variants. Side effects, especially after the second dose of a COVID-19 ...

  9. Neoadjuvant Combination Targeted and Immunotherapy for Patients With High-Risk Stage III Melanoma - Mayo Clinic

    Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Giving vemurafenib, cobimetinib, and ...

  10. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find ...